C4 Therapeutics, Inc.

CCCC

$3.71

-0.80%

2026-09-04 09:49:32 EDT-$0.03

Healthcare

Biotechnology

NASDAQ

Active Trading

C4 Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapeutic candidates. Its core strategy involves degrading proteins ...

Historical Employee Count of CCCC

Current

104

Change

-5.45%

Minimum

104

Maximum

146

Recent Filings

Report Date	Employees	Form Type	Filing Date	SEC Filing
Dec 31, 2025	104	10-K	Feb 26, 2026	View
Dec 31, 2024	110	10-K	Feb 27, 2025	View
Dec 31, 2023	145	10-K	Feb 22, 2024	View
Dec 31, 2022	146	10-K	Feb 23, 2023	View
Dec 31, 2021	121	10-K	Feb 24, 2022	View

Supply Chain of CCCC

Upstream / Downstream / Proxies

Upstream

China Baowu Steel Group (Baoshan Iron & Steel)SSE:600019HBIS Group (Hesteel)Anhui Conch Cement Company Ltd.SEHK:0914 China National Building Material Co., Ltd. (CNBM)SEHK:3323SANY Heavy Industry Co., Ltd.SSE:600031XCMG Construction Machinery Co., Ltd.SZSE:000425Zoomlion Heavy Industry Science & Technology Co., Ltd.SZSE:000157Shanghai Zhenhua Heavy Industries Co., Ltd. (ZPMC)SSE:600320CCCC Dredging (Group) Co., Ltd.Vale S.A.NYSE:VALE BHP Group Ltd.NYSE:BHP Rio Tinto GroupNYSE:RIO Weichai Power Co., Ltd.SEHK:2338 Cummins Inc.NYSE:CMISinopec (China Petroleum & Chemical Corp.)SSE:600028

Downstream

Ministry of Transport, People's Republic of ChinaProvincial Transportation Departments (various Chinese provinces)China State Railway Group Co., Ltd.Local Chinese Municipal GovernmentsSri Lanka Ports AuthorityGovernment of Pakistan (CPEC Authority)Government of KenyaGovernment of IndonesiaGovernment of MalaysiaChina Harbour Engineering Company (CHEC)China Road and Bridge Corporation (CRBC)China Development Bank (CDB)Export-Import Bank of China (Exim Bank)

Proxies

China State Construction Engineering Corp. (CSCEC)SSE:601668China Railway Group Ltd. (CREC)SSE:601390China Railway Construction Corp. (CRCC)SSE:601186Vinci SAEPA:DG

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer